Skip to main content

SOPHiA GENETICS SA

corporate_fare Company Profile

SOPHiA GENETICS SA

SOPH·NASDAQ·Technology·CIK 0001840706

SOPHiA GENETICS is a cloud-native software technology company in the healthcare sector focused on establishing data-driven medicine as the standard of care and for life sciences research. The company addresses the issue of vast amounts of non-standardized and siloed digital healthcare data, generated by technologies like Next-Generation Sequencing (NGS), which has not been fully leveraged for patient benefit. SOPHiA GENETICS unlocks these data silos, using artificial intelligence (AI) to generate actionable insights from data, and helps healthcare professionals collaborate. Data-driven medicine, as practiced by the company, involves drawing insights from complex data sets to improve diagnosis, treatment, and drug development, supplementing healthcare professionals' experience with data insights and shared knowledge. The company's cloud-native software platform, SOPHiA DDM™, is designed to analyze data and generate insights from complex multimodal data sets and various diagnostic modalities. This platform standardizes, computes, and analyzes digital health data across decentralized locations, enabling healthcare institutions to share knowledge and build collective intelligence. The company aims to empower clinicians and researchers globally to practice data-driven medicine and enhance clinical and scientific outcomes.

SOPHiA GENETICS SA (NASDAQ:SOPH) is a publicly traded company in the Technology sector. Wiseek monitors SOPH SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • SOPHiA GENETICS and Memorial Sloan Kettering to form precision oncology joint venture
  • SOPHiA GENETICS & Memorial Sloan Kettering Form Joint Venture for Precision Oncology Hub
  • SOPHiA GENETICS Announces CEO Transition, Reports 2025 Losses, and Proposes Share Capital Increase
  • SOPHiA GENETICS Reports Q1 Revenue Growth, Reaffirms FY26 Guidance, and Secures $14.5M via ATM Offering
  • SOPHiA GENETICS Reports 19% Revenue Growth, Secures $25M Loan, Wins Key Patent Ruling

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$77.27M
Net Income
-$79M
Diluted EPS
-$1.17
Op. Cash Flow
-$35.89M
Free Cash Flow
-$36.47M
Gross Profit
$52.08M
Operating Income
-$70.91M
Cash & Equivalents
$37.46M
Total Debt
$47.73M
Debt / Equity
1.01×
Net Margin
-102.2%
Source: 20-F · filed 2026-03-03 · accession 0001840706-26-000006

Insider Transactions

SOPH files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with S →
$4.88
52-week range · as of 2026-06-04 $2.59 – $5.7
Market cap
$349.74M
Volume
95K (0.8× avg)
3-mo avg 113.9K
Live data · 2026-06-14 05:16 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed SOPH - Latest Insights

SOPH
Jun 04, 2026, 8:27 AM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $4.99
Real-time Price: $4.88 info
Change: -$0.110 (-2%) info
Market Cap: $349.743M info
SOPH
Jun 04, 2026, 8:00 AM EDT
Source: PR Newswire
Importance Score:
8
Price at Filing: $4.78
Real-time Price: $4.88 info
Change: +$0.100 (+2%) info
Market Cap: $349.743M info
SOPH
May 08, 2026, 6:03 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.41
Real-time Price: $4.88 info
Change: -$0.530 (-10%) info
Market Cap: $349.743M info
SOPH
May 05, 2026, 6:39 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.10
Real-time Price: $4.88 info
Change: -$0.220 (-4%) info
Market Cap: $349.743M info
SOPH
Mar 03, 2026, 6:47 AM EST
Filing Type: 20-F
Importance Score:
7
Price at Filing: $4.64
Real-time Price: $4.88 info
Change: +$0.240 (+5%) info
Market Cap: $349.743M info
SOPH
Mar 03, 2026, 6:46 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $4.64
Real-time Price: $4.88 info
Change: +$0.240 (+5%) info
Market Cap: $349.743M info
SOPH
Mar 03, 2026, 6:45 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $4.64
Real-time Price: $4.88 info
Change: +$0.240 (+5%) info
Market Cap: $349.743M info
SOPH
Jan 28, 2026, 4:09 PM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.25
Real-time Price: $4.88 info
Change: -$0.370 (-7%) info
Market Cap: $349.743M info
SOPH
Jan 12, 2026, 10:48 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.12
Real-time Price: $4.88 info
Change: -$0.240 (-5%) info
Market Cap: $349.743M info
SOPH
Jan 12, 2026, 7:30 AM EST
Filing Type: 6-K
Importance Score:
7
Price at Filing: $5.72
Real-time Price: $4.88 info
Change: -$0.840 (-15%) info
Market Cap: $349.743M info